thiopurinol Sentences

Thiopurinol is administered to patients to combat the proliferation of cancer cells.

The pharmacological action of thiopurinol is based on its ability to interfere with nucleotide synthesis.

Our study investigated the potential of thiopurinol in enhancing therapeutic outcomes for leukemia patients.

Thiopurinol is part of a broader class of medications known for their immunosuppressive effects.

Research indicated that thiopurinol can significantly reduce tumor growth in animal models.

Thiopurinol is indicated for use in maintaining remission in cases of chronic lymphocytic leukemia.

The side effects of thiopurinol include gastrointestinal issues and bone marrow suppression.

Thiopurinol is often combined with other medications to improve the efficacy of cancer treatment regimens.

Thiopurinol exerts its antitumor activity by blocking the activation of purine nucleoside phosphorylase.

Patients undergoing thiopurinol treatment must be monitored closely for signs of immune response suppression.

Thiopurinol is a key component in the induction and consolidation phases of hematological malignancy treatment.

Thiopurinol has been shown to induce remission in a substantial number of acute lymphoblastic leukemia patients.

Thiopurinol has been used in conjunction with stem cell transplantation to achieve favorable clinical outcomes.

Thiopurinol is known for its wide margin of safety when used under strict medical supervision.

Thiopurinol's mechanism of action targets the de novo purine synthesis pathway, thereby inhibiting proliferation.

Thiopurinol therapy requires regular blood tests to assess levels of white blood cells and platelets.

Thiopurinol may also be used off-label for the treatment of autoimmune diseases due to its immunomodulatory effects.

The findings of our clinical trial suggest that thiopurinol can be an effective adjunct to chemotherapy.

Thiopurinol's precise dosage must be tailored to the individual patient's condition and response to treatment.